Atrial Fibrillation and Worse Outcomes in ST-Segment–Elevation Myocardial Infarction

Atrial Fibrillation and Worse Outcomes in ST-Segment–Elevation Myocardial Infarction Editorial Atrial Fibrillation and Worse Outcomes in ST- Segment–Elevation Myocardial Infarction Is It All About Infarct Size, or Do We Need to Look Elsewhere? Promporn Suksaranjit, MD, MS; Brent D. Wilson, MD, PhD trial fibrillation (AF) is a common cardiac arrhythmia in analysis of data from a CMR substudy of the AIDA STEMI Apatients admitted to a hospital with myocardial infarction trial (Abciximab Intracoronary Versus Intravenous Drug (MI). In a large study looking at 106 780 patients, AF preva- Application in ST-Elevation Myocardial Infarction). They lence was 22%, with half of AF patients presenting with and used CMR data from this large, multicenter STEMI trial to half developing AF during their hospitalization for acute MI. examine the association between the presence of AF during With the use of implantable cardiac monitoring, AF incidence hospitalization and infarct characteristics by CMR and major was as high as 39% at 24 months in post-MI patients with left adverse cardiovascular events at 12 months after primary ventricular systolic dysfunction. The relationship between percutaneous coronary intervention (PPCI). A total of 786 AF and MI is complex and bidirectional, but it is clear that MI patients with STEMI who underwent CMR were included in 3,4 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Circulation: Cardiovascular Imaging Wolters Kluwer Health

Atrial Fibrillation and Worse Outcomes in ST-Segment–Elevation Myocardial Infarction

Loading next page...
 
/lp/wolters_kluwer/atrial-fibrillation-and-worse-outcomes-in-st-segment-elevation-4gTTENV8Ui
Publisher
Wolters Kluwer
Copyright
© 2018 American Heart Association, Inc.
ISSN
1941-9651
eISSN
1942-0080
D.O.I.
10.1161/CIRCIMAGING.118.007472
Publisher site
See Article on Publisher Site

Abstract

Editorial Atrial Fibrillation and Worse Outcomes in ST- Segment–Elevation Myocardial Infarction Is It All About Infarct Size, or Do We Need to Look Elsewhere? Promporn Suksaranjit, MD, MS; Brent D. Wilson, MD, PhD trial fibrillation (AF) is a common cardiac arrhythmia in analysis of data from a CMR substudy of the AIDA STEMI Apatients admitted to a hospital with myocardial infarction trial (Abciximab Intracoronary Versus Intravenous Drug (MI). In a large study looking at 106 780 patients, AF preva- Application in ST-Elevation Myocardial Infarction). They lence was 22%, with half of AF patients presenting with and used CMR data from this large, multicenter STEMI trial to half developing AF during their hospitalization for acute MI. examine the association between the presence of AF during With the use of implantable cardiac monitoring, AF incidence hospitalization and infarct characteristics by CMR and major was as high as 39% at 24 months in post-MI patients with left adverse cardiovascular events at 12 months after primary ventricular systolic dysfunction. The relationship between percutaneous coronary intervention (PPCI). A total of 786 AF and MI is complex and bidirectional, but it is clear that MI patients with STEMI who underwent CMR were included in 3,4

Journal

Circulation: Cardiovascular ImagingWolters Kluwer Health

Published: Feb 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from Google Scholar, PubMed
Create lists to organize your research
Export lists, citations
Access to DeepDyve database
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off